Narrative review / 2006
Dietary IP6 and inositol demonstrate anticancer effects in experimental models and preliminary benefits in human cancer studies.
This review evaluates the efficacy and mechanisms of dietary inositol hexaphosphate (IP6) and inositol in cancer prevention and therapy. IP6 has been shown to reduce cell proliferation, induce malignant cell differentiation, and exert antioxidant and immune-enhancing properties in various experimental models. Preliminary studies in humans suggest that IP6 plus inositol appears to enhance the anticancer effect of conventional chemotherapy, control cancer metastases, and improve quality of life.
- Study type
- Narrative review
- Who was studied
- Human and experimental cancer models
- What was measured
- Anticancer efficacy, mechanisms, quality of life, metastasis control
THE PAPER
Protection against cancer by dietary IP6 and inositol.
Vucenik I, Shamsuddin AM. Nutr Cancer, 2006.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.